References
- Ochsner J L, Decamp P T, Leonard G L. Experience with fresh venous allografts as an arterial substitute. Ann Surg. 1971; 173: 933–939
- Tice D A, Zerbino V. Clinical experience with preserved human allografts for vascular reconstruction. Surgery 1972; 72: 260–267
- Calhoun A D, Baur G N, Porter J M, Houghton D H, Templeton I W. Fresh and cryopreserved venous allografts in genetically characterized dogs. J Surg Res. 1977; 22: 687–696
- Stevens S L, Tyler J D, Freeman M B, Hopkins F, Lewis T, Bray J, Edwards A L, Brockland K, Goldman M H. Factors affecting patency of venous allografts in miniature swine. J Vasc Surg. 1990; 12: 361–366
- Merhi Y, Roy R, Douville Y, Ben-Slimane S, Guzman R, Downs A, Hebert J, Roy P E, Guidoin R. Fresh venous femoral autografts and allografts as carotid substitutes in matched dogs from the same litter. J Cardiovasc Surg. 1990; 31: 147–155
- Ochsner J L, Lawson J D, Eskind S J, Mills N L, Decamp F T. Homologous veins as an arterial substitute: long-term results. J Vasc Surg. 1984; 1: 306–313
- Harjola P T, Scheinin T M, Tiilikainen A. Factors affecting early patency of human venous allografts in arterial reconstruction. Ann Clin Res. 1969; 1: 169–176
- Vegeto A, Berardinelli L, Malan E. Use of homologous vein grafts for chronic hemodialysis. J Cardiovasc Surg. 1977; 18: 501–504
- Gelbfish J, Jacobowitz I J, Rose D M, Connolly M W, Acinapura A J, Zisbrod Z, Lim K H, Cappabianca P, Cunningham J N. Cryopreserved homologous saphenous vein: early and late patency in coronary artery bypass surgical procedures. Ann Thorac Surg. 1986; 42: 70–73
- Stephen M, Sheil R, Wing J. Allograft vein arterial bypass. Arch Surg. 1978; 113: 591–593
- Suciu-Foca N, Reed E, Marboe C, Harris P, Xi Y P, Yu-Kai S, Ho E, Reemstma K, King D W. The role of anti-HLA antibodies in heart transplantation. Transplantation 1991; 51: 716–724
- London R E, Wilson R L, Shield C F, III, Ferrone S. Humoral immunity in renal transplantation: detection of cytotoxic antibodies to lymphocyte antigens rather than HLA-A, B, C and la-like antigens in patients with vascular graft rejection. Transplantation 1981; 32: 286–290
- Moraes J R, Stastny P. Human endothelial cell antigens: molecular independency from HLC expression in blood monocytes. Transplant Proc. 1977; 9: 605–607
- Paul L C, van Es L A, Rood J J. Accelerated rejection of a renal allograft associated with pre-transplantation antibodies directed against donor antigens on endothelium and monocytes. N Engl J Med. 1979; 301: 1258–1260
- Jordan S C, Yap H K, Sakai R S, Alfonso P, Fitchman M. Hyperacute allograft rejection mediated by anti-vascular endothelial cell antibodies with a negative monocyte crossmatch. Transplantation 1988; 46: 585–587
- Trento A, Hardesty R L, Griffith B P, Zerbe T, Kormos R L, Bahnson H T. Role of the antibody to vascular endothelial cells in hyperacute rejection in patients undergoing cardiac transplantation. J Thorac Cardiovasc Surg. 1988; 95: 37–41
- D'Anastasio C, Impallomeni M, McPherson G AD, Clements W G, Howells C L, Brooks P A, Batchelor J R. Antibodies against monocytes and endothelial cells in the sera of patients with atherosclerotic peripheral arterial disease. Atherosclerosis 1988; 74: 99–105
- Cerilli J, Brasile L, Karmody A. Role of the vascular endothelial cell antigen system in the etiology of atherosclerosis. Ann Surg. 1985; 202: 329–334
- Baguley E, Hugher G RV. Lytic IgG anti-endothelial cell antibodies in vasculitis. Lancet 1988; 2: 907